Polyrizon (PLRZ) Stock Price, Quote, News & History

Polyrizon Ltd (PLRZ) Stock Price, Quote, News & History

PLRZNASDAQ

Trade with Public

$12.52

0.847.19%

Last update: Apr 1, 12:33 PM

Key Statistics

Open

$12.99

Volume / Avg.

16.79K / 82.18K

Day Range

$11.41 - $12.99

52 Wk Range

2.88 - 2.24K

Market Cap

$20.31M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.43%

Days to Cover

1.23

Recent Polyrizon Ltd News

Polyrizon Stock Skyrockets After New Data Shows Naloxone Gel Outperforms Marketed Spray

Polyrizon stock is up on new data showing its naloxone hydrogel formulation has stronger and longer-lasting mucosal retention.

Vandana Singh

What Sparked Polyrizon's (PLRZ) 140% After-Hours Stock Surge?

Polyrizon surged in nearly 140% after-hours trading following preclinical data showing its naloxone hydrogel outperforms a marketed spray and a key manufacturing milestone.

Mohd Haider

Polyrizon Hits Key Breakthrough That Brings Its Nasal Spray Closer To 2026 Trials

Polyrizon jumps over 100%. The company completes major manufacturing milestone for its proprietary nasal-spray product platform.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-4.53M

Investing Cash Flow (TTM)

-16.53M

Financing Cash Flow (TTM)

19.81M

Free Cash Flow (TTM)

-4.54M

Capital Expenditure (TTM)

-7.00K

Net Change in Cash (TTM)

-1.25M

Valuation Metrics

Enterprise Value

$19.53M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.90

Earnings Yield % (TTM)

-41.95%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$12.94

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$1.31M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$12.99

Volume / Avg.

16.79K / 82.18K

Day Range

$11.41 - $12.99

52 Wk Range

2.88 - 2.24K

Market Cap

$20.31M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.43%

Days to Cover

1.23

About

Sector

Health Care

Industry

Biotechnology

Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also con...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Polyrizon (PLRZ) stock?

You can purchase shares of Polyrizon (NASDAQ:PLRZ) through any online brokerage.

View our list of the best stock brokerages

Who are Polyrizon (PLRZ) competitors?

Other companies in Polyrizon’s space includes: Outlook Therapeutics Inc (NASDAQ:OTLK), Skye Bioscience Inc (NASDAQ:SKYE), Curis Inc (NASDAQ:CRIS), Intensity Therapeutics Inc (NASDAQ:INTS) and Nanoviricides Inc (AMEX:NNVC).

What is the forecast, or price target, for Polyrizon (PLRZ) stock?

There is no analysis for Polyrizon to provide a consensus price target.

What is the current price for Polyrizon (PLRZ)?

The stock price for Polyrizon (NASDAQ: PLRZ) is $12.52 last updated April 1, 2026 at 12:33 PM EDT.

Does Polyrizon (PLRZ) pay a dividend?

There are no upcoming dividends for Polyrizon.

When is Polyrizon (NASDAQ:PLRZ) reporting earnings?

Polyrizon does not have any upcoming earnings scheduled.

Is Polyrizon (PLRZ) going to split?

There is no upcoming split for Polyrizon.

What sector and industry does Polyrizon (PLRZ) operate in?

Polyrizon is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Outlook Therapeutics Inc

Intensity Therapeutics Inc

Barinthus Biotherapeutics PLC

NASDAQ:BRNS

$0.54

-5.10%

Vistagen Therapeutics Inc

NASDAQ:VTGN

$0.60

4.92%

Tevogen Bio Holdings Inc

NASDAQ:TVGN

$4.54

0.44%

Key Statistics

Open

$12.99

Volume / Avg.

16.79K / 82.18K

Day Range

$11.41 - $12.99

52 Wk Range

2.88 - 2.24K

Market Cap

$20.31M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.43%

Days to Cover

1.23

Recent Polyrizon Ltd News

Polyrizon Stock Skyrockets After New Data Shows Naloxone Gel Outperforms Marketed Spray

Polyrizon stock is up on new data showing its naloxone hydrogel formulation has stronger and longer-lasting mucosal retention.

Vandana Singh

What Sparked Polyrizon's (PLRZ) 140% After-Hours Stock Surge?

Polyrizon surged in nearly 140% after-hours trading following preclinical data showing its naloxone hydrogel outperforms a marketed spray and a key manufacturing milestone.

Mohd Haider

Polyrizon Hits Key Breakthrough That Brings Its Nasal Spray Closer To 2026 Trials

Polyrizon jumps over 100%. The company completes major manufacturing milestone for its proprietary nasal-spray product platform.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-4.53M

Investing Cash Flow (TTM)

-16.53M

Financing Cash Flow (TTM)

19.81M

Free Cash Flow (TTM)

-4.54M

Capital Expenditure (TTM)

-7.00K

Net Change in Cash (TTM)

-1.25M

Valuation Metrics

Enterprise Value

$19.53M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.90

Earnings Yield % (TTM)

-41.95%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$12.94

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$1.31M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$12.99

Volume / Avg.

16.79K / 82.18K

Day Range

$11.41 - $12.99

52 Wk Range

2.88 - 2.24K

Market Cap

$20.31M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.43%

Days to Cover

1.23

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry